Convalife Pharmaceuticals

Shanghai, China · Founded 2015 · In IPO Registration

Researcher and developer of innovative drugs focused on oncology treatments. Convalife Pharmaceuticals is based in Shanghai, China and was founded in 2015. Its last reported valuation was $445 million in Jul 2025. It has raised $59.8 million.

Last reported valuation

$444.6M

Oct 2026

Priced at

—

Total raised

$59.8M

Last round

—

How much has Convalife Pharmaceuticals raised?

$59.8Macross 0 recorded rounds

Free account

More of Convalife Pharmaceuticals with a free account

·The complete investor list: 12 names
·Watch Convalife Pharmaceuticals: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Convalife Pharmaceuticals investors

12 investors are on record for Convalife Pharmaceuticals, including Optics Valley Financial Holdings Group, Fujian Shangrun Investment Management, Beijing Chuangye Letu Technology Group and Chengrong Investment.

For fundraisers

Raising for a company like Convalife Pharmaceuticals?

12 investors have backed Convalife Pharmaceuticals.

See all 12 investors →

Frequently asked about Convalife Pharmaceuticals

How much has Convalife Pharmaceuticals raised?: Convalife Pharmaceuticals has raised $59.8M in total across 0 recorded funding rounds.